Eagle Strategies LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1907666 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$408,330

-$37,514 QoQ

Shares Held

3,232

+1.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#1,480

of 2,266 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eagle Strategies LLC holds $8,022,452 across 6 Drug Manufacturers - General names. GILD ranks #5 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	4,271	$5,122,765
2	JNJ	Johnson & Johnson	3,678	$934,101
3	ABBV	AbbVie Inc.	3,262	$820,849
4	NVS	Novartis AG	2,616	$409,979
5	GILD	Gilead Sciences, Inc. This page	3,232	$408,330
6	PFE	Pfizer Inc	13,556	$326,428

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$408,330	3,232	+1.0%	Shares	Sole	2026-07-21
2026-03-31	$445,844	3,199	+1.3%	Shares	Sole	2026-04-20
2025-12-31	$387,735	3,159	+0.8%	Shares	Sole	2026-01-23
2025-09-30	$347,874	3,134	+0.6%	Shares	Sole	2025-10-21
2025-06-30	$345,360	3,115	+0.6%	Shares	Sole	2025-07-23
2025-03-31	$346,794	3,095	+0.1%	Shares	Sole	2025-04-23
2024-12-31	$285,515	3,091	+1.3%	Shares	Sole	2025-02-14
2024-06-30	$209,260	3,050	-4.7%	Shares	Sole	2024-08-08
2024-03-31	$234,326	3,199	+4.3%	Shares	Sole	2024-04-23
2023-12-31	$248,376	3,066	+1.4%	Shares	Sole	2024-01-26
2023-09-30	$226,543	3,023	+2.0%	Shares	Sole	2023-11-08
2023-06-30	$228,512	2,965	+0.1%	Shares	Sole	2023-08-03
2023-03-31	$245,674	2,961	+0.1%	Shares	Sole	2023-04-24
2022-12-31	$253,858	2,957	—	Shares	Sole	2023-02-06
No filing history on record for this holder in this stock.